- Home
- Publications
- Publication Search
- Publication Details
Title
Health Technology Assessment in Osteoporosis
Authors
Keywords
Burden of disease, Cost-effectiveness, Economic evaluation, Health technology assessment, Osteoporosis
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 93, Issue 1, Pages 1-14
Publisher
Springer Nature
Online
2013-03-20
DOI
10.1007/s00223-013-9724-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)
- (2012) C. Cooper et al. CURRENT MEDICAL RESEARCH AND OPINION
- Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland
- (2012) K. Lippuner et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- A systematic review of hip fracture incidence and probability of fracture worldwide
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland
- (2012) Mickaël Hiligsmann et al. VALUE IN HEALTH
- Cost-Effectiveness of Different Strategies for Selecting and Treating Individuals at Increased Risk of Osteoporosis or Osteopenia: A Systematic Review
- (2012) Dirk Müller et al. VALUE IN HEALTH
- Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007)
- (2012) Mickaël Hiligsmann et al. ARTHRITIS CARE & RESEARCH
- The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis
- (2012) Mickaël Hiligsmann et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Use of a Decision Aid to Improve Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial
- (2011) Victor M. Montori et al. AMERICAN JOURNAL OF MEDICINE
- FRAX® with and without Bone Mineral Density
- (2011) John A. Kanis et al. CALCIFIED TISSUE INTERNATIONAL
- Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women
- (2011) Stephen Gehlbach et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Economics of Improving Medication Adherence in Osteoporosis: Validation and Application of a Simulation Model
- (2011) Amanda R. Patrick et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoporosis: now and the future
- (2011) Tilman D Rachner et al. LANCET
- Pitfalls in the external validation of FRAX
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Guidance for the adjustment of FRAX according to the dose of glucocorticoids
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Partial adherence: a new perspective on health economic assessment in osteoporosis
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Interpretation and use of FRAX in clinical practice
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Secular trends in the incidence of hip and other osteoporotic fractures
- (2011) C. Cooper et al. OSTEOPOROSIS INTERNATIONAL
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
- (2011) Mickaël Hiligsmann et al. PHARMACOECONOMICS
- Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2
- (2011) David C. Hoaglin et al. VALUE IN HEALTH
- PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONS
- (2011) M. Hiligsmann et al. VALUE IN HEALTH
- A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence
- (2011) Susan Ross et al. VALUE IN HEALTH
- The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands
- (2011) R. Akehurst et al. JOURNAL OF MEDICAL ECONOMICS
- Osteoporosis: burden, health care provision and opportunities in the EU
- (2011) O. Ström et al. Archives of Osteoporosis
- Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
- (2010) Mickaël Hiligsmann et al. BONE
- FRAX® and its applications in health economics—Cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example
- (2010) O. Ström et al. BONE
- The societal burden of poor persistence to treatment of osteoporosis in Sweden
- (2010) Erik Landfeldt et al. BONE
- Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications
- (2010) Mickaël Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients
- (2010) Mickaël Hiligsmann et al. HEALTH POLICY
- Perspective how many women have osteoporosis?
- (2010) L. Joseph Melton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoporosis: impact on health and economics
- (2010) Nicholas Harvey et al. Nature Reviews Rheumatology
- Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club
- (2010) J.-J. Body et al. OSTEOPOROSIS INTERNATIONAL
- A FRAX® model for the assessment of fracture probability in Belgium
- (2010) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Patient preferences for osteoporosis in Spain: a discrete choice experiment
- (2010) J. Darbà et al. OSTEOPOROSIS INTERNATIONAL
- Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement
- (2010) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- Age, cohort and period effects on hip fracture incidence: analysis and predictions from New Zealand data 1974-2007
- (2010) J. Langley et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
- (2010) B. Jönsson et al. OSTEOPOROSIS INTERNATIONAL
- Patient education in groups increases knowledge of osteoporosis and adherence to treatment: A two-year randomized controlled trial
- (2010) Dorthe Nielsen et al. PATIENT EDUCATION AND COUNSELING
- Does the Funding Source Influence the Results in Economic Evaluations?
- (2010) Rachael L. Fleurence et al. PHARMACOECONOMICS
- Overcoming problems with adherence to osteoporosis medication
- (2010) Véronique Rabenda et al. Expert Review of Pharmacoeconomics & Outcomes Research
- An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women
- (2010) John A. Kanis et al. Archives of Osteoporosis
- A Comparison of Prediction Models for Fractures in Older Women
- (2009) Kristine E. Ensrud ARCHIVES OF INTERNAL MEDICINE
- Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years
- (2009) Mickaël Hiligsmann et al. BONE
- History of HTA: Introduction
- (2009) David Banta et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Incidence and Mortality of Hip Fractures in the United States
- (2009) Carmen A. Brauer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Adherence on Lifetime Fractures in Osteoporotic Women Treated With Daily and Weekly Bisphosphonates
- (2009) Mark D Danese et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review
- (2009) T. Gleeson et al. OSTEOPOROSIS INTERNATIONAL
- Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women
- (2009) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate
- (2009) K. Kayan et al. OSTEOPOROSIS INTERNATIONAL
- Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997–2006
- (2009) B. Abrahamsen et al. OSTEOPOROSIS INTERNATIONAL
- Excess mortality following hip fracture: a systematic epidemiological review
- (2009) B. Abrahamsen et al. OSTEOPOROSIS INTERNATIONAL
- Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis
- (2009) Mickaël Hiligsmann et al. VALUE IN HEALTH
- Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report
- (2009) Michael Drummond et al. VALUE IN HEALTH
- Health economics of osteoporosis
- (2008) Fredrik Borgström et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women
- (2008) Mickaël Hiligsmann et al. BONE
- Harmonization of evidence requirements for health technology assessment in reimbursement decision making
- (2008) John Hutton et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Patients’ preferences for osteoporosis drug treatment: a discrete choice experiment
- (2008) E. W. de Bekker-Grob et al. OSTEOPOROSIS INTERNATIONAL
- Incorporating adherence into health economic modelling of osteoporosis
- (2008) O. Ström et al. OSTEOPOROSIS INTERNATIONAL
- Secular trends in hip fracture incidence and recurrence
- (2008) L. J. Melton et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effective osteoporosis treatment thresholds: the United States perspective
- (2008) A. N. A. Tosteson et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Conducting Discrete Choice Experiments to Inform Healthcare Decision Making
- (2008) Emily Lancsar et al. PHARMACOECONOMICS
- The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates
- (2008) S. Rietbrock et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests
- (2008) Irina Cleemput et al. VALUE IN HEALTH
- Cost Effectiveness of Screen-and-Treat Strategies for Low Bone Mineral Density
- (2008) John T Schousboe Applied Health Economics and Health Policy
- A model of the public health impact of improved treatment persistence in post-menopausal osteoporosis in France
- (2007) François-Emery Cotté et al. JOINT BONE SPINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started